Page 84 - GPD-2-2
P. 84

Gene & Protein in Disease





                                        ORIGINAL RESEARCH ARTICLE
                                        Verteporfin induces YAP-dependent cell cycle

                                        arrest and caspase-mediated cellular apoptosis
                                        in triple-negative breast cancer cells



                                        Sulfath Thottungal Parambil, Gisha Rose Antony,  Ajeesh Babu Littleflower,
                                        and Lakshmi Subhadradevi*
                                        Laboratory of Molecular Medicine, Division of Cancer Research, Regional Cancer Centre (Research
                                        Centre, University of Kerala), Thiruvananthapuram, Kerala, India




                                        Abstract
                                        Triple-negative breast cancer (TNBC) subtype endows distinctive biological features,
                                        including aberrant proliferation, and deducing the molecular mechanism harmonizing
                                        the TNBC characteristics is crucial for a greater understanding and prognosis of the
                                        disease. The aim of the present study was to analyze the anti-tumorigenic effects of
                                        verteporfin (VP) in TNBC in vitro. We evaluated the tumorigenic properties of TNBC
                                        cells on VP treatment to assess the cell viability, apoptosis, cell cycle, cell survival,
                                        and protein/mRNA expressions in MDA-MB-231 and SUM-159 breast cancer cells.
                                        Transient silencing of yes-associated protein (YAP) was performed to validate the
                                        data. TNBC cells exhibited a comparatively higher active YAP downstream signaling,
                                        and VP resulted in the nuclear exclusion of YAP to a significant extent. VP inhibits
                                        the  proliferation of  TNBC  cells by altering cyclin-dependent kinase  inhibitors,
                                        thereby rendering cellular arrest at the G0/G1 phase. In a dose-dependent manner,
            *Corresponding author:      VP induces the apoptotic machinery in TNBC cells. Moreover, transient silencing of
            Lakshmi Subhadradevi        YAP in TNBC cells exhibited a similar pattern of antiproliferative effects. Elevated YAP
            (rcc.lakshmi@gmail.com)
                                        nuclear activity and downstream signaling in TNBC are associated with sustaining
            Citation: Parambil ST, Antony GR,   the proliferative capacity of the cells by inhibiting cellular apoptosis. VP induces
            Littleflower AB, et al., 2023,
            Verteporfin induces YAP-dependent   antiproliferative effects on TNBC through cytoplasmic retention of YAP. Consequently,
            cell cycle arrest and caspase-  cells rewire the course of the cell cycle and stimulate cellular death. We suggest YAP
            mediated cellular apoptosis in triple-  signaling as a prerequisite for TNBC cell progression, and VP without light activation
            negative breast cancer cells. Gene
            Protein Dis, 2(2): 0658.    exerts anti-tumorigenic effects on TNBC cells.
            https://doi.org/10.36922/gpd.0658
            Received: April 19, 2023    Keywords: Verteporfin; Triple-negative breast cancer; Yes-associated protein; Cell cycle;
            Accepted: June 26, 2023
            Published Online: July 7, 2023  Hippo signaling
            Copyright: © 2023 Author(s).
            This is an Open Access article
            distributed under the terms of the
            Creative Commons Attribution   1. Introduction
            License, permitting distribution,
            and reproduction in any medium,   The  groundbreaking  effort  to unravel  molecular  portraits  of breast  cancer  by Perou
            provided the original work is   et al. has shed considerable light on the possibility of various classes of breast cancer .
                                                                                                           [1]
            properly cited.             The absence of hormone receptors (estrogen receptors and progesterone receptors) and
            Publisher’s Note: AccScience   lack of overexpressed human epidermal growth factor receptor-2 (HER-2) in triple-
            Publishing remains neutral with   negative breast cancer (TNBC) is highly unfavorable for the patients as the hormone
            regard to jurisdictional claims in
            published maps and institutional   therapy and monoclonal antibody administration will not applicable like the hormone-
                                                                        [2]
            affiliations.               receptor-positive breast cancer subtypes . TNBC incidences comprise 15 – 20% of all

            Volume 2 Issue 2 (2023)                         1                        https://doi.org/10.36922/gpd.0658
   79   80   81   82   83   84   85   86   87   88   89